Lupin Limited has informed the Exchange regarding a press release dated December 21, 2022, titled “Lupin Receives Approval from U.S. FDA for Brivaracetam Tablets.”…….
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Lupin Limited has informed the Exchange regarding a press release dated December 21, 2022, titled “Lupin Receives Approval from U.S. FDA for Brivaracetam Tablets.”…….
| Subscribe To Our Free Newsletter |
